ID   ATF5_RAT                Reviewed;         281 AA.
AC   Q6P788; Q8CIT6;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   08-NOV-2023, entry version 135.
DE   RecName: Full=Cyclic AMP-dependent transcription factor ATF-5;
DE            Short=cAMP-dependent transcription factor ATF-5;
DE   AltName: Full=Activating transcription factor 5;
DE   AltName: Full=Transcription factor ATFx;
GN   Name=Atf5; Synonyms=Atfx;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, INDUCTION, AND FUNCTION.
RC   STRAIN=New England Deaconess Hospital;
RX   PubMed=12805299; DOI=10.1523/jneurosci.23-11-04590.2003;
RA   Angelastro J.M., Ignatova T.N., Kukekov V.G., Steindler D.A.,
RA   Stengren G.B., Mendelsohn C., Greene L.A.;
RT   "Regulated expression of ATF5 is required for the progression of neural
RT   progenitor cells to neurons.";
RL   J. Neurosci. 23:4590-4600(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=19531563; DOI=10.1158/1541-7786.mcr-08-0365;
RA   Li G., Li W., Angelastro J.M., Greene L.A., Liu D.X.;
RT   "Identification of a novel DNA binding site and a transcriptional target
RT   for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer
RT   cells.";
RL   Mol. Cancer Res. 7:933-943(2009).
RN   [4]
RP   FUNCTION, AND INDUCTION BY PRO-APOPTOTIC STIMULI.
RX   PubMed=21212266; DOI=10.1074/jbc.m110.207639;
RA   Dluzen D., Li G., Tacelosky D., Moreau M., Liu D.X.;
RT   "BCL-2 is a downstream target of ATF5 that mediates the prosurvival
RT   function of ATF5 in a cell type-dependent manner.";
RL   J. Biol. Chem. 286:7705-7713(2011).
RN   [5]
RP   FUNCTION, INTERACTION WITH EP300, ACETYLATION AT LYS-29, AND MUTAGENESIS OF
RP   LYS-29.
RX   PubMed=21791614; DOI=10.1128/mcb.05887-11;
RA   Liu D.X., Qian D., Wang B., Yang J.M., Lu Z.;
RT   "p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and
RT   cell proliferation and survival.";
RL   Mol. Cell. Biol. 31:3906-3916(2011).
CC   -!- FUNCTION: Transcription factor that either stimulates or represses gene
CC       transcription through binding of different DNA regulatory elements such
CC       as cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'),
CC       ATF5-specific response element (ARE) (consensus: 5'-
CC       C[CT]TCT[CT]CCTT[AT]-3') but also the amino acid response element
CC       (AARE), present in many viral and cellular promoters. Critically
CC       involved, often in a cell type-dependent manner, in cell survival,
CC       proliferation, and differentiation. Its transcriptional activity is
CC       enhanced by CCND3 and slightly inhibited by CDK4 (By similarity)
CC       (PubMed:19531563, PubMed:21212266). Important regulator of the cerebral
CC       cortex formation, functions in cerebral cortical neuroprogenitor cells
CC       to maintain proliferation and to block differentiation into neurons.
CC       Must be down-regulated in order for such cells to exit the cycle and
CC       differentiate (By similarity) (PubMed:12805299). Participates in the
CC       pathways by which SHH promotes cerebellar granule neuron progenitor
CC       cells proliferation. Critical for survival of mature olfactory sensory
CC       neurons (OSN), directs expression of OSN-specific genes (By
CC       similarity). May be involved in osteogenic differentiation. Promotes
CC       cell proliferation and survival by inducing the expression of EGR1
CC       sinergistically with ELK1. Once acetylated by EP300, binds to ARE
CC       sequences on target genes promoters, such as BCL2 and EGR1 (By
CC       similarity) (PubMed:21791614). Plays an anti-apoptotic role through the
CC       transcriptional regulation of BCL2, this function seems to be cell
CC       type-dependent (By similarity). Cooperates with NR1I3/CAR in the
CC       transcriptional activation of CYP2B6 in liver. In hepatic cells,
CC       represses CRE-dependent transcription and inhibits proliferation by
CC       blocking at G2/M phase. May act as a negative regulator of IL1B
CC       transduction pathway in liver. Upon IL1B stimulus, cooperates with NLK
CC       to activate the transactivation activity of C/EBP subfamily members.
CC       Besides its function of transcription factor, acts as a cofactor of
CC       CEBPB to activate CEBPA and promote adipocyte differentiation.
CC       Regulates centrosome dynamics in a cell-cycle- and centriole-age-
CC       dependent manner. Forms 9-foci symmetrical ring scaffold around the
CC       mother centriole to control centrosome function and the interaction
CC       between centrioles and pericentriolar material (By similarity).
CC       {ECO:0000250|UniProtKB:O70191, ECO:0000250|UniProtKB:Q9Y2D1,
CC       ECO:0000269|PubMed:12805299, ECO:0000269|PubMed:19531563,
CC       ECO:0000269|PubMed:21212266, ECO:0000269|PubMed:21791614}.
CC   -!- SUBUNIT: Binds DNA as a dimer. Interacts with PTP4A1/PRL-1 (By
CC       similarity). Interacts with CCND3, but not with CCND1 or CCND2.
CC       Interacts with HSPA1A or HSPA1B; the interaction protects ATF5 from
CC       degradation via proteasome-dependent and caspase-dependent processes.
CC       Interacts (via C-terminal region) with NPM1 (via C-terminal region);
CC       the interaction leads to loss of association between HSPA1A or HSPA1B
CC       and ATF5 and promotes ATF5 degradation via proteasome-dependent and
CC       caspase-dependent processes. Interacts with NLK; the interaction
CC       stabilizes ATF5 at the protein level in a kinase-independent manner.
CC       Interacts with alpha-tubulin, gamma-tubulin members TUBGCP2 and
CC       TUBGCP4, PCNT; the ATF5:PCNT:polyglutamylated tubulin (PGT) tripartite
CC       unites the mother centriole and the pericentriolar material (PCM) in
CC       the centrosome (By similarity). Interacts with CEBPB and EP300; EP300
CC       is required for ATF5 and CEBPB interaction and DNA binding (By
CC       similarity) (PubMed:21791614). {ECO:0000250|UniProtKB:O70191,
CC       ECO:0000250|UniProtKB:Q9Y2D1, ECO:0000269|PubMed:21791614}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y2D1}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9Y2D1, ECO:0000255|PROSITE-ProRule:PRU00978}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:Q9Y2D1}. Note=Actively transported to the
CC       centrosome and accumulated in the pericentriolar material (PCM) during
CC       G1 to M phase via a microtubule-dependent mechanism. During late
CC       telophase and cytokinesis, translocates from the centrosome to the
CC       midbody. {ECO:0000250|UniProtKB:Q9Y2D1}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryonic nasal epithelium, dorsal
CC       root, trigeminal ganglia, brain and liver. Within the brain, expression
CC       is highest in the ventricular zone and decreased in structures
CC       containing migrating and postmitotic neurons (at protein level).
CC       {ECO:0000269|PubMed:12805299}.
CC   -!- INDUCTION: Down-regulated during neuronal differentiation. Down-
CC       regulated by pro-apoptotic stimuli (PubMed:21212266).
CC       {ECO:0000269|PubMed:12805299, ECO:0000269|PubMed:21212266}.
CC   -!- PTM: Ubiquitinated by CDC34 and UBE2B in order to be degraded by the
CC       proteasome. {ECO:0000250}.
CC   -!- PTM: Acetylated at Lys-29 by EP300, the acetylation enhances the
CC       interaction with CEBPB, DNA-binding and transactivation activity.
CC       {ECO:0000269|PubMed:21791614}.
CC   -!- PTM: Ubiquitinated by CDC34 and UBE2B in order to be degraded by the
CC       proteasome. Cisplatin inhibits ubiquitination and proteasome-mediated
CC       degradation by inhibiting the interaction with CDC34. Ubiquitination
CC       and degradation by the proteasome are inhibited by NLK in a kinase-
CC       independent manner. {ECO:0000250|UniProtKB:Q9Y2D1}.
CC   -!- PTM: Phosphorylated by NLK, probably at Ser-92 and Ser-126.
CC       {ECO:0000250|UniProtKB:Q9Y2D1}.
CC   -!- SIMILARITY: Belongs to the bZIP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY123225; AAM92263.1; -; mRNA.
DR   EMBL; BC061786; AAH61786.1; -; mRNA.
DR   RefSeq; NP_758839.3; NM_172336.3.
DR   RefSeq; XP_006229042.1; XM_006228980.2.
DR   RefSeq; XP_017444334.1; XM_017588845.1.
DR   AlphaFoldDB; Q6P788; -.
DR   SMR; Q6P788; -.
DR   BioGRID; 251873; 1.
DR   STRING; 10116.ENSRNOP00000027260; -.
DR   iPTMnet; Q6P788; -.
DR   PhosphoSitePlus; Q6P788; -.
DR   PaxDb; 10116-ENSRNOP00000027260; -.
DR   GeneID; 282840; -.
DR   KEGG; rno:282840; -.
DR   UCSC; RGD:628902; rat.
DR   AGR; RGD:628902; -.
DR   CTD; 22809; -.
DR   RGD; 628902; Atf5.
DR   eggNOG; KOG4571; Eukaryota.
DR   InParanoid; Q6P788; -.
DR   OrthoDB; 4324582at2759; -.
DR   PhylomeDB; Q6P788; -.
DR   TreeFam; TF316136; -.
DR   PRO; PR:Q6P788; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:RGD.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; ISO:RGD.
DR   GO; GO:0021930; P:cerebellar granule cell precursor proliferation; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0045444; P:fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; IMP:RGD.
DR   GO; GO:1902750; P:negative regulation of cell cycle G2/M phase transition; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IDA:RGD.
DR   GO; GO:0021891; P:olfactory bulb interneuron development; ISO:RGD.
DR   GO; GO:0021889; P:olfactory bulb interneuron differentiation; ISO:RGD.
DR   GO; GO:0021988; P:olfactory lobe development; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0046605; P:regulation of centrosome cycle; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd14692; bZIP_ATF4; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   PANTHER; PTHR13044; ACTIVATING TRANSCRIPTION FACTOR ATF 4/5; 1.
DR   PANTHER; PTHR13044:SF3; CYCLIC AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-5; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PRINTS; PR01217; PRICHEXTENSN.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Cytoplasm; Cytoskeleton; DNA-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..281
FT                   /note="Cyclic AMP-dependent transcription factor ATF-5"
FT                   /id="PRO_0000076588"
FT   DOMAIN          207..270
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          1..21
FT                   /note="Required for protein stabilization induced by IL1B"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y2D1"
FT   REGION          118..152
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          119..216
FT                   /note="Interaction with PTP4A1"
FT                   /evidence="ECO:0000250|UniProtKB:O70191"
FT   REGION          166..236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          209..229
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          235..249
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   COMPBIAS        120..149
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        179..198
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        206..236
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         29
FT                   /note="N6-acetyllysine; by EP300"
FT                   /evidence="ECO:0000269|PubMed:21791614"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y2D1"
FT   MUTAGEN         29
FT                   /note="K->R: Not acetylated by EP300."
FT                   /evidence="ECO:0000269|PubMed:21791614"
FT   CONFLICT        193
FT                   /note="L -> P (in Ref. 1; AAM92263)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   281 AA;  30205 MW;  FBBF68FB44F9C601 CRC64;
     MSLLATLGLE LDRALLPASG LGWLVDYGKL PLAPAPLGPY EVLGGALEGG LPGGGEPLAG
     DGFSDWMTER VDFTALLPLE APLPPGTLPP PSPAPPDLEA MASLLKKELE QMEDFFLDAP
     LLPPPSPPPP PPPAPSLPLP LPLPTFDLPQ PPTLDTLDLL AVYCRSEAGP GDSGLTTLPV
     PQQPPPLAPL PSLSRPAPYP SPASTRGDRK QKKRDQNKSA ALRYRQRKRA EGEALEGECQ
     GLEARNRELR ERAESVEREI QYVKDLLIEV YKARSQRTRS A
//
